Victoria funds free MenB vaccine for Year 10s — and $250 is the number

What just happened

Victoria’s 2026–27 state budget committed more than $9 million to fund the meningococcal B vaccine free for all Year 10 students, beginning 1 January 2027. The vaccine will be delivered through existing school immunisation programs and will also be available at GPs, pharmacies, local council immunisation services, and Aboriginal health services.

The number that matters is $250. That is what the MenB vaccine currently costs out of pocket, privately, for a teenager who is not in an age group covered by the National Immunisation Program. This budget commitment removes that cost for one cohort, in one state.

If you have a teenager in Year 10 next year — or know someone who does — this is the news. Not because the vaccine is new. It is not new. MenB (Bexsero®) has been TGA-approved and available in Australia for years. The barrier was never the science. The barrier was the cost, and the cost determined who got it.

The RACGP described the announcement as “lifesaving.” That word is not rhetorical. Meningococcal B disease kills young people quickly — within 24 hours of first symptoms in severe cases. Survivors can lose limbs or hearing. The organism does not allow a slow diagnostic process. The value of vaccination against it is real.

---

The both-and

This is a genuine step forward — with genuine gaps worth naming.

Year 10 students — roughly 15 to 16 years old — are one of the highest-risk groups for meningococcal B in Australian epidemiological data. The disease shows two distinct peaks: infancy, and adolescence. During the adolescent window, social mixing, close contact in shared spaces, and a period of naturally lower immunity align in a way that raises risk. Victoria’s decision to target Year 10 is scientifically grounded.

But the age gaps are worth holding at the same time.

MenB is already funded on the National Immunisation Program for infants — at 2, 4, and 12 months of age. A child born today gets those early doses free. The window between approximately age 2 and Year 10, and then the years beyond Year 10, remains privately funded at a cost that many families in public schools have been absorbing or skipping.

Victoria is moving first among Australian states and territories. No other state or territory currently funds MenB in an adolescent school-based program. Whether this creates pressure for a national PBAC review of the adolescent threshold — or remains a Victorian anomaly — is an open question.

Two other groups sit outside this announcement. Older Year 10 students who are age-equivalent but enrolled differently may need checking for eligibility via their school’s immunisation program. And young adults in university residential colleges, share houses, and other high-contact settings face comparable risk without comparable access. Those individuals are not in this budget.

The science of MenB vaccination in adolescents is settled. The funding model is not — and Victoria just changed part of it.

---

2 cents

For Victorian families with a current Year 9 student — who will be in Year 10 in 2027 — the programme is coming. Watch for the school immunisation notification, which typically arrives with the school immunisation schedule early in the year. The vaccine will be offered on-site. If your child misses the school session, GPs, pharmacies, and community immunisation services will have access at no cost.

For families with older teenagers, or with young adults who have moved through the Year 10 window without the vaccine: the conversation with a GP is worth having. The vaccine is available privately. At current rates of approximately $120–$150 per dose in most areas, and a two-dose course for adolescents and young adults who have not been vaccinated previously, the total is real — but it is less than a weekend, and meningococcal B disease can remove a life in under 24 hours.

For families outside Victoria: the NIP for infants covers the early doses. For the adolescent window, no state program exists yet. The conversation with your GP about private MenB vaccination is the same one it has always been — the difference now is that Victoria’s commitment may accelerate a federal conversation about broadening the NIP.

This is general information. Whether the MenB vaccine is appropriate for a specific person depends on age, prior vaccination history, and individual medical history. That is a conversation for your GP.

---

Verdict

Verdict: yes — worth knowing about.

Victoria has funded MenB vaccination for Year 10 students from January 2027. The $250 private cost barrier is removed for that cohort, in that state. The gaps are real: the years between infant NIP doses and Year 10, and the years beyond, remain privately funded. Young adults in high-contact living arrangements sit outside the announcement entirely. For Victorian families with a 15- to 16-year-old next year: the programme is coming. For everyone else: the conversation with your GP has not changed — the vaccine is available, the disease is fast, and cost is the only reason most families have deferred.

---

Sources cited

1. Victorian Premier — Protecting Victorian Teens From Meningococcal B
2. RACGP — GPs praise Victorian budget’s ‘lifesaving’ meningococcal B and ADHD reforms
3. Newshub/Medianet — GPs praise Victorian budget’s meningococcal B and ADHD reforms
4. health.vic.gov.au — NIP and state-funded vaccines for adults
5. Mirage News — Protecting Victorian Teens From Meningococcal B